Table of Content

1 Pet Disease Drugs Market Overview
1.1 Product Overview and Scope of Pet Disease Drugs
1.2 Pet Disease Drugs Segment by Type
1.2.1 Global Pet Disease Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Parasiticides
1.2.3 Anti-infectives
1.2.4 Anti-inflammatory
1.2.5 Analgesics
1.2.6 Others
1.3 Pet Disease Drugs Segment by Application
1.3.1 Global Pet Disease Drugs Market Value by Application: (2024-2034)
1.3.2 Infectious Diseases
1.3.3 Dermatologic Diseases
1.3.4 Pain
1.3.5 Orthopedic Diseases
1.3.6 Behavioral Diseases
1.3.7 Other
1.4 Global Pet Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Pet Disease Drugs Revenue 2024-2034
1.4.2 Global Pet Disease Drugs Sales 2024-2034
1.4.3 Global Pet Disease Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Pet Disease Drugs Market Competition by Manufacturers
2.1 Global Pet Disease Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global Pet Disease Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Pet Disease Drugs Average Price by Manufacturers (2024-2024)
2.4 Global Pet Disease Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Pet Disease Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Disease Drugs, Product Type & Application
2.7 Pet Disease Drugs Market Competitive Situation and Trends
2.7.1 Pet Disease Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Disease Drugs Players Market Share by Revenue
2.7.3 Global Pet Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Disease Drugs Retrospective Market Scenario by Region
3.1 Global Pet Disease Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Pet Disease Drugs Global Pet Disease Drugs Sales by Region: 2024-2034
3.2.1 Global Pet Disease Drugs Sales by Region: 2024-2024
3.2.2 Global Pet Disease Drugs Sales by Region: 2024-2034
3.3 Global Pet Disease Drugs Global Pet Disease Drugs Revenue by Region: 2024-2034
3.3.1 Global Pet Disease Drugs Revenue by Region: 2024-2024
3.3.2 Global Pet Disease Drugs Revenue by Region: 2024-2034
3.4 North America Pet Disease Drugs Market Facts & Figures by Country
3.4.1 North America Pet Disease Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Pet Disease Drugs Sales by Country (2024-2034)
3.4.3 North America Pet Disease Drugs Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Disease Drugs Market Facts & Figures by Country
3.5.1 Europe Pet Disease Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Pet Disease Drugs Sales by Country (2024-2034)
3.5.3 Europe Pet Disease Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Disease Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Disease Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Pet Disease Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific Pet Disease Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pet Disease Drugs Market Facts & Figures by Country
3.7.1 Latin America Pet Disease Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Pet Disease Drugs Sales by Country (2024-2034)
3.7.3 Latin America Pet Disease Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Disease Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Disease Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Pet Disease Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa Pet Disease Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Disease Drugs Sales by Type (2024-2034)
4.1.1 Global Pet Disease Drugs Sales by Type (2024-2024)
4.1.2 Global Pet Disease Drugs Sales by Type (2024-2034)
4.1.3 Global Pet Disease Drugs Sales Market Share by Type (2024-2034)
4.2 Global Pet Disease Drugs Revenue by Type (2024-2034)
4.2.1 Global Pet Disease Drugs Revenue by Type (2024-2024)
4.2.2 Global Pet Disease Drugs Revenue by Type (2024-2034)
4.2.3 Global Pet Disease Drugs Revenue Market Share by Type (2024-2034)
4.3 Global Pet Disease Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global Pet Disease Drugs Sales by Application (2024-2034)
5.1.1 Global Pet Disease Drugs Sales by Application (2024-2024)
5.1.2 Global Pet Disease Drugs Sales by Application (2024-2034)
5.1.3 Global Pet Disease Drugs Sales Market Share by Application (2024-2034)
5.2 Global Pet Disease Drugs Revenue by Application (2024-2034)
5.2.1 Global Pet Disease Drugs Revenue by Application (2024-2024)
5.2.2 Global Pet Disease Drugs Revenue by Application (2024-2034)
5.2.3 Global Pet Disease Drugs Revenue Market Share by Application (2024-2034)
5.3 Global Pet Disease Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 Ceva
6.2.1 Ceva Corporation Information
6.2.2 Ceva Description and Business Overview
6.2.3 Ceva Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Ceva Pet Disease Drugs Product Portfolio
6.2.5 Ceva Recent Developments/Updates
6.3 Vetoquinol S.A.
6.3.1 Vetoquinol S.A. Corporation Information
6.3.2 Vetoquinol S.A. Description and Business Overview
6.3.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
6.3.5 Vetoquinol S.A. Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Zoetis Pet Disease Drugs Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Virbac Pet Disease Drugs Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Bimeda
6.6.1 Bimeda Corporation Information
6.6.2 Bimeda Description and Business Overview
6.6.3 Bimeda Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Bimeda Pet Disease Drugs Product Portfolio
6.6.5 Bimeda Recent Developments/Updates
6.7 Calier
6.6.1 Calier Corporation Information
6.6.2 Calier Description and Business Overview
6.6.3 Calier Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Calier Pet Disease Drugs Product Portfolio
6.7.5 Calier Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Corporation Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 Elanco Animal Health
6.9.1 Elanco Animal Health Corporation Information
6.9.2 Elanco Animal Health Description and Business Overview
6.9.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
6.9.5 Elanco Animal Health Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Corporation Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
6.11 Norbrook Laboratories
6.11.1 Norbrook Laboratories Corporation Information
6.11.2 Norbrook Laboratories Pet Disease Drugs Description and Business Overview
6.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
6.11.5 Norbrook Laboratories Recent Developments/Updates
6.12 Chanelle Pharma
6.12.1 Chanelle Pharma Corporation Information
6.12.2 Chanelle Pharma Pet Disease Drugs Description and Business Overview
6.12.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
6.12.5 Chanelle Pharma Recent Developments/Updates
6.13 K-Laser USA
6.13.1 K-Laser USA Corporation Information
6.13.2 K-Laser USA Pet Disease Drugs Description and Business Overview
6.13.3 K-Laser USA Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 K-Laser USA Pet Disease Drugs Product Portfolio
6.13.5 K-Laser USA Recent Developments/Updates
6.14 Assisi Animal Health
6.14.1 Assisi Animal Health Corporation Information
6.14.2 Assisi Animal Health Pet Disease Drugs Description and Business Overview
6.14.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
6.14.5 Assisi Animal Health Recent Developments/Updates
6.15 Multi Radiance Medical
6.15.1 Multi Radiance Medical Corporation Information
6.15.2 Multi Radiance Medical Pet Disease Drugs Description and Business Overview
6.15.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
6.15.5 Multi Radiance Medical Recent Developments/Updates
6.16 Avazzia
6.16.1 Avazzia Corporation Information
6.16.2 Avazzia Pet Disease Drugs Description and Business Overview
6.16.3 Avazzia Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Avazzia Pet Disease Drugs Product Portfolio
6.16.5 Avazzia Recent Developments/Updates
6.17 SOUND Technologies
6.17.1 SOUND Technologies Corporation Information
6.17.2 SOUND Technologies Pet Disease Drugs Description and Business Overview
6.17.3 SOUND Technologies Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 SOUND Technologies Pet Disease Drugs Product Portfolio
6.17.5 SOUND Technologies Recent Developments/Updates
6.18 IRM Enterprises
6.18.1 IRM Enterprises Corporation Information
6.18.2 IRM Enterprises Pet Disease Drugs Description and Business Overview
6.18.3 IRM Enterprises Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.18.4 IRM Enterprises Pet Disease Drugs Product Portfolio
6.18.5 IRM Enterprises Recent Developments/Updates
6.19 Ashish Life Science
6.19.1 Ashish Life Science Corporation Information
6.19.2 Ashish Life Science Pet Disease Drugs Description and Business Overview
6.19.3 Ashish Life Science Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Ashish Life Science Pet Disease Drugs Product Portfolio
6.19.5 Ashish Life Science Recent Developments/Updates
6.20 Century Pharmaceuticals
6.20.1 Century Pharmaceuticals Corporation Information
6.20.2 Century Pharmaceuticals Pet Disease Drugs Description and Business Overview
6.20.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
6.20.5 Century Pharmaceuticals Recent Developments/Updates
6.21 VETINDIA Pharmaceuticals
6.21.1 VETINDIA Pharmaceuticals Corporation Information
6.21.2 VETINDIA Pharmaceuticals Pet Disease Drugs Description and Business Overview
6.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.21.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
6.21.5 VETINDIA Pharmaceuticals Recent Developments/Updates
6.22 Ourofino Animal Health
6.22.1 Ourofino Animal Health Corporation Information
6.22.2 Ourofino Animal Health Pet Disease Drugs Description and Business Overview
6.22.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
6.22.5 Ourofino Animal Health Recent Developments/Updates
6.23 SeQuent Scientific
6.23.1 SeQuent Scientific Corporation Information
6.23.2 SeQuent Scientific Pet Disease Drugs Description and Business Overview
6.23.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.23.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
6.23.5 SeQuent Scientific Recent Developments/Updates
6.24 LABINDIA Healthcare
6.24.1 LABINDIA Healthcare Corporation Information
6.24.2 LABINDIA Healthcare Pet Disease Drugs Description and Business Overview
6.24.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.24.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
6.24.5 LABINDIA Healthcare Recent Developments/Updates
6.25 Morvel Laboratories
6.25.1 Morvel Laboratories Corporation Information
6.25.2 Morvel Laboratories Pet Disease Drugs Description and Business Overview
6.25.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.25.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
6.25.5 Morvel Laboratories Recent Developments/Updates
6.26 Richter Pharma
6.26.1 Richter Pharma Corporation Information
6.26.2 Richter Pharma Pet Disease Drugs Description and Business Overview
6.26.3 Richter Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.26.4 Richter Pharma Pet Disease Drugs Product Portfolio
6.26.5 Richter Pharma Recent Developments/Updates
6.27 Zuche Pharmaceuticals
6.27.1 Zuche Pharmaceuticals Corporation Information
6.27.2 Zuche Pharmaceuticals Pet Disease Drugs Description and Business Overview
6.27.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.27.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
6.27.5 Zuche Pharmaceuticals Recent Developments/Updates
6.28 Fidelis Animal Health
6.28.1 Fidelis Animal Health Corporation Information
6.28.2 Fidelis Animal Health Pet Disease Drugs Description and Business Overview
6.28.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2024-2024)
6.28.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
6.28.5 Fidelis Animal Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Disease Drugs Industry Chain Analysis
7.2 Pet Disease Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Disease Drugs Production Mode & Process
7.4 Pet Disease Drugs Sales and Marketing
7.4.1 Pet Disease Drugs Sales Channels
7.4.2 Pet Disease Drugs Distributors
7.5 Pet Disease Drugs Customers
8 Pet Disease Drugs Market Dynamics
8.1 Pet Disease Drugs Industry Trends
8.2 Pet Disease Drugs Market Drivers
8.3 Pet Disease Drugs Market Challenges
8.4 Pet Disease Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pet Disease Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pet Disease Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pet Disease Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pet Disease Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Pet Disease Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Pet Disease Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Pet Disease Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Pet Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Pet Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Pet Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Pet Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Disease Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Disease Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Pet Disease Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global Pet Disease Drugs Sales Market Share by Region (2024-2024)
Table 19. Global Pet Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Pet Disease Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Pet Disease Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Pet Disease Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global Pet Disease Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pet Disease Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Pet Disease Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Pet Disease Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Pet Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pet Disease Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Pet Disease Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Pet Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pet Disease Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Pet Disease Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Pet Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Pet Disease Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Pet Disease Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pet Disease Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Pet Disease Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Pet Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pet Disease Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pet Disease Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Pet Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Pet Disease Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pet Disease Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global Pet Disease Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Pet Disease Drugs Sales Market Share by Type (2024-2024)
Table 53. Global Pet Disease Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Pet Disease Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Pet Disease Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pet Disease Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global Pet Disease Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Pet Disease Drugs Price (US$/Unit) by Type (2024-2024)
Table 59. Global Pet Disease Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global Pet Disease Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global Pet Disease Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Pet Disease Drugs Sales Market Share by Application (2024-2024)
Table 63. Global Pet Disease Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Pet Disease Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Pet Disease Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pet Disease Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global Pet Disease Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Pet Disease Drugs Price (US$/Unit) by Application (2024-2024)
Table 69. Global Pet Disease Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Merck & Co., Inc. Corporation Information
Table 71. Merck & Co., Inc. Description and Business Overview
Table 72. Merck & Co., Inc. Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck & Co., Inc. Pet Disease Drugs Product
Table 74. Merck & Co., Inc. Recent Developments/Updates
Table 75. Ceva Corporation Information
Table 76. Ceva Description and Business Overview
Table 77. Ceva Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Ceva Pet Disease Drugs Product
Table 79. Ceva Recent Developments/Updates
Table 80. Vetoquinol S.A. Corporation Information
Table 81. Vetoquinol S.A. Description and Business Overview
Table 82. Vetoquinol S.A. Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Vetoquinol S.A. Pet Disease Drugs Product
Table 84. Vetoquinol S.A. Recent Developments/Updates
Table 85. Zoetis Corporation Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Zoetis Pet Disease Drugs Product
Table 89. Zoetis Recent Developments/Updates
Table 90. Virbac Corporation Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Virbac Pet Disease Drugs Product
Table 94. Virbac Recent Developments/Updates
Table 95. Bimeda Corporation Information
Table 96. Bimeda Description and Business Overview
Table 97. Bimeda Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Bimeda Pet Disease Drugs Product
Table 99. Bimeda Recent Developments/Updates
Table 100. Calier Corporation Information
Table 101. Calier Description and Business Overview
Table 102. Calier Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Calier Pet Disease Drugs Product
Table 104. Calier Recent Developments/Updates
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Boehringer Ingelheim Pet Disease Drugs Product
Table 109. Boehringer Ingelheim Recent Developments/Updates
Table 110. Elanco Animal Health Corporation Information
Table 111. Elanco Animal Health Description and Business Overview
Table 112. Elanco Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Elanco Animal Health Pet Disease Drugs Product
Table 114. Elanco Animal Health Recent Developments/Updates
Table 115. Dechra Pharmaceuticals Corporation Information
Table 116. Dechra Pharmaceuticals Description and Business Overview
Table 117. Dechra Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Dechra Pharmaceuticals Pet Disease Drugs Product
Table 119. Dechra Pharmaceuticals Recent Developments/Updates
Table 120. Norbrook Laboratories Corporation Information
Table 121. Norbrook Laboratories Description and Business Overview
Table 122. Norbrook Laboratories Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Norbrook Laboratories Pet Disease Drugs Product
Table 124. Norbrook Laboratories Recent Developments/Updates
Table 125. Chanelle Pharma Corporation Information
Table 126. Chanelle Pharma Description and Business Overview
Table 127. Chanelle Pharma Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Chanelle Pharma Pet Disease Drugs Product
Table 129. Chanelle Pharma Recent Developments/Updates
Table 130. K-Laser USA Corporation Information
Table 131. K-Laser USA Description and Business Overview
Table 132. K-Laser USA Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. K-Laser USA Pet Disease Drugs Product
Table 134. K-Laser USA Recent Developments/Updates
Table 135. Assisi Animal Health Corporation Information
Table 136. Assisi Animal Health Description and Business Overview
Table 137. Assisi Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Assisi Animal Health Pet Disease Drugs Product
Table 139. Assisi Animal Health Recent Developments/Updates
Table 140. Multi Radiance Medical Corporation Information
Table 141. Multi Radiance Medical Description and Business Overview
Table 142. Multi Radiance Medical Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Multi Radiance Medical Pet Disease Drugs Product
Table 144. Multi Radiance Medical Recent Developments/Updates
Table 145. Avazzia Corporation Information
Table 146. Avazzia Description and Business Overview
Table 147. Avazzia Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Avazzia Pet Disease Drugs Product
Table 149. Avazzia Recent Developments/Updates
Table 150. SOUND Technologies Corporation Information
Table 151. SOUND Technologies Description and Business Overview
Table 152. SOUND Technologies Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. SOUND Technologies Pet Disease Drugs Product
Table 154. SOUND Technologies Recent Developments/Updates
Table 155. IRM Enterprises Corporation Information
Table 156. IRM Enterprises Description and Business Overview
Table 157. IRM Enterprises Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. IRM Enterprises Pet Disease Drugs Product
Table 159. IRM Enterprises Recent Developments/Updates
Table 160. Ashish Life Science Corporation Information
Table 161. Ashish Life Science Description and Business Overview
Table 162. Ashish Life Science Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Ashish Life Science Pet Disease Drugs Product
Table 164. Ashish Life Science Recent Developments/Updates
Table 165. Century Pharmaceuticals Corporation Information
Table 166. Century Pharmaceuticals Description and Business Overview
Table 167. Century Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Century Pharmaceuticals Pet Disease Drugs Product
Table 169. Century Pharmaceuticals Recent Developments/Updates
Table 170. VETINDIA Pharmaceuticals Corporation Information
Table 171. VETINDIA Pharmaceuticals Description and Business Overview
Table 172. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. VETINDIA Pharmaceuticals Pet Disease Drugs Product
Table 174. VETINDIA Pharmaceuticals Recent Developments/Updates
Table 175. Ourofino Animal Health Corporation Information
Table 176. Ourofino Animal Health Description and Business Overview
Table 177. Ourofino Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Ourofino Animal Health Pet Disease Drugs Product
Table 179. Ourofino Animal Health Recent Developments/Updates
Table 180. SeQuent Scientific Corporation Information
Table 181. SeQuent Scientific Description and Business Overview
Table 182. SeQuent Scientific Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. SeQuent Scientific Pet Disease Drugs Product
Table 184. SeQuent Scientific Recent Developments/Updates
Table 185. LABINDIA Healthcare Corporation Information
Table 186. LABINDIA Healthcare Description and Business Overview
Table 187. LABINDIA Healthcare Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. LABINDIA Healthcare Pet Disease Drugs Product
Table 189. LABINDIA Healthcare Recent Developments/Updates
Table 190. Morvel Laboratories Corporation Information
Table 191. Morvel Laboratories Description and Business Overview
Table 192. Morvel Laboratories Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 193. Morvel Laboratories Pet Disease Drugs Product
Table 194. Morvel Laboratories Recent Developments/Updates
Table 195. Richter Pharma Corporation Information
Table 196. Richter Pharma Description and Business Overview
Table 197. Richter Pharma Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 198. Richter Pharma Pet Disease Drugs Product
Table 199. Richter Pharma Recent Developments/Updates
Table 200. Zuche Pharmaceuticals Corporation Information
Table 201. Zuche Pharmaceuticals Description and Business Overview
Table 202. Zuche Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 203. Zuche Pharmaceuticals Pet Disease Drugs Product
Table 204. Zuche Pharmaceuticals Recent Developments/Updates
Table 205. Fidelis Animal Health Corporation Information
Table 206. Fidelis Animal Health Description and Business Overview
Table 207. Fidelis Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 208. Fidelis Animal Health Pet Disease Drugs Product
Table 209. Fidelis Animal Health Recent Developments/Updates
Table 210. Key Raw Materials Lists
Table 211. Raw Materials Key Suppliers Lists
Table 212. Pet Disease Drugs Distributors List
Table 213. Pet Disease Drugs Customers List
Table 214. Pet Disease Drugs Market Trends
Table 215. Pet Disease Drugs Market Drivers
Table 216. Pet Disease Drugs Market Challenges
Table 217. Pet Disease Drugs Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Disease Drugs
Figure 2. Global Pet Disease Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pet Disease Drugs Market Share by Type in 2022 & 2034
Figure 4. Parasiticides Product Picture
Figure 5. Anti-infectives Product Picture
Figure 6. Anti-inflammatory Product Picture
Figure 7. Analgesics Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pet Disease Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Pet Disease Drugs Market Share by Application in 2022 & 2034
Figure 11. Infectious Diseases
Figure 12. Dermatologic Diseases
Figure 13. Pain
Figure 14. Orthopedic Diseases
Figure 15. Behavioral Diseases
Figure 16. Other
Figure 17. Global Pet Disease Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 18. Global Pet Disease Drugs Market Size (2024-2034) & (US$ Million)
Figure 19. Global Pet Disease Drugs Sales (2024-2034) & (K Units)
Figure 20. Global Pet Disease Drugs Average Price (US$/Unit) & (2024-2034)
Figure 21. Pet Disease Drugs Report Years Considered
Figure 22. Pet Disease Drugs Sales Share by Manufacturers in 2022
Figure 23. Global Pet Disease Drugs Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Pet Disease Drugs Players: Market Share by Revenue in 2022
Figure 25. Pet Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 26. Global Pet Disease Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 27. North America Pet Disease Drugs Sales Market Share by Country (2024-2034)
Figure 28. North America Pet Disease Drugs Revenue Market Share by Country (2024-2034)
Figure 29. United States Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Canada Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Europe Pet Disease Drugs Sales Market Share by Country (2024-2034)
Figure 32. Europe Pet Disease Drugs Revenue Market Share by Country (2024-2034)
Figure 33. Germany Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. France Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. U.K. Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Italy Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Russia Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Asia Pacific Pet Disease Drugs Sales Market Share by Region (2024-2034)
Figure 39. Asia Pacific Pet Disease Drugs Revenue Market Share by Region (2024-2034)
Figure 40. China Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Japan Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. South Korea Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. India Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Australia Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. China Taiwan Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Latin America Pet Disease Drugs Sales Market Share by Country (2024-2034)
Figure 48. Latin America Pet Disease Drugs Revenue Market Share by Country (2024-2034)
Figure 49. Mexico Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Brazil Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Argentina Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Pet Disease Drugs Sales Market Share by Country (2024-2034)
Figure 53. Middle East & Africa Pet Disease Drugs Revenue Market Share by Country (2024-2034)
Figure 54. Turkey Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. UAE Pet Disease Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Pet Disease Drugs by Type (2024-2034)
Figure 58. Global Revenue Market Share of Pet Disease Drugs by Type (2024-2034)
Figure 59. Global Pet Disease Drugs Price (US$/Unit) by Type (2024-2034)
Figure 60. Global Sales Market Share of Pet Disease Drugs by Application (2024-2034)
Figure 61. Global Revenue Market Share of Pet Disease Drugs by Application (2024-2034)
Figure 62. Global Pet Disease Drugs Price (US$/Unit) by Application (2024-2034)
Figure 63. Pet Disease Drugs Value Chain
Figure 64. Pet Disease Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed